نتایج جستجو برای: thrombopoietin receptor

تعداد نتایج: 591318  

Journal: :Blood 1974
S Ebbe

By Shirley Ebbe I T HAS BEEN CLEAR for almost 20 years that platelet production is subject to homeostatic regulatory mechanisms that result in stimulation when the platelet count is li w’ and suppression when it is high.2 In spite of elapsed time, the physiologic processes that are involved in those regulatory mechanisms are not clear. Thrombocytopoiesis may be regulated by a humoral thrombopoi...

Journal: :Blood 2012
Fiorina Giona Luciana Teofili Maria Luisa Moleti Maurizio Martini Giovanna Palumbo Angela Amendola Maria Gabriella Mazzucconi Anna Maria Testi Patrizia Pignoloni Sonia Maria Orlando Sara Capodimonti Mauro Nanni Giuseppe Leone Luigi Maria Larocca Robin Foà

Sixty-four patients < 20 years of age, investigated for a suspicion of Philadelphia-negative myeloproliferative disease (MPD), were retrospectively evaluated to characterize the different forms and to examine the treatments used and long-term outcome. JAK2 mutations, endogenous erythroid colony growth, and clonality were investigated in 51 children. Mutations of thrombopoietin, the thrombopoiet...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1999
K Ihara

Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare disorder expressed in infancy and characterized by isolated thrombocytopenia and megakaryocytopenia with no physical anomalies. Our previous hematological analysis indicated similarities between human CAMT and murine c-mpl (thrombopoietin receptor) deficiency. Because the c-mpl gene was considered as one of the candidate genes for thi...

2015
Drew Provan Adrian C. Newland

Primary immune thrombocytopenia is an autoimmune disorder of unknown cause affecting both children and adults. The low peripheral blood platelet count is caused by premature platelet destruction by self-reacting antibodies in addition to an impairment of platelet production. The disease is heterogeneous in its pathophysiology, clinical features and responses to treatment. To date, most of the t...

Journal: :Molecular pathology : MP 1999
S Duensing A Duensing J G Meran A Kreft G Büsche A Ganser A Georgii

BACKGROUND Chronic myeloproliferative disorders (CMPD) originate from a pluripotent haematopoietic progenitor cell but show a marked degree of heterogeneity, especially between Philadelphia chromosome positive and negative disease entities. Abnormal megakaryopoiesis is a frequent finding in CMPD, often associated with thrombocythaemic cell counts. Recent experimental data have suggested that th...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید